Stay updated on Pembrolizumab + Gemcitabine in UC Subjects Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Gemcitabine in UC Subjects Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Gemcitabine in UC Subjects Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The type of intervention has been updated from version v2.13.3 to v2.14.0.
    Difference
    0.1%
    Check dated 2025-01-12T18:30:16.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The website has been updated from version v2.13.2 to v2.13.3.
    Difference
    0.0%
    Check dated 2024-12-14T22:50:10.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study and includes a reference to the Contacts and Locations section.
    Difference
    2%
    Check dated 2024-12-07T16:21:15.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    New features have been added to the website, while several options related to participant groups, interventions, and data download formats have been removed.
    Difference
    2%
    Check dated 2024-11-23T04:44:26.000Z thumbnail image
  8. Check
    60 days ago
    Change Detected
    Summary
    Several key health-related resources have been removed, including links to MedlinePlus genetics information and various drug information pages on DailyMed.
    Difference
    0.3%
    Check dated 2024-11-15T23:59:49.000Z thumbnail image
  9. Check
    68 days ago
    Change Detected
    Summary
    The website has been updated to version 2.12.2, with new resources added for bladder cancer and related treatments, including links to MedlinePlus and DailyMed for drug information.
    Difference
    3%
    Check dated 2024-11-08T18:30:49.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Gemcitabine in UC Subjects Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Gemcitabine in UC Subjects Clinical Trial page.